Issue Cover

Press Releases

Breaking news from across the pharma sector

Articles

Verisense Health Adopts Datavant’s Data Connectivity Platform to Expand its Digital Health Panel
Verisense Health Adopts Datavant’s Data Connectivity Platform to Expand its Digital Health Panel

Verisense® Health, Inc., a digital health technology and data company, today announced that it is adopting Datavant’s data connectivity platform to facilitate linking its Digital Health Panel to other real-world data (RWD) sources and further progress objective, digital health research.

13 February 2024Press Releases
ELRIG UK Announces Steve Bates and Dr Anderson Ryan as Keynote Speakers at Research and Innovation
ELRIG UK Announces Steve Bates and Dr Anderson Ryan as Keynote Speakers at Research and Innovation

The European Laboratory Research & Innovation Group (ELRIG) UK today announced the keynote speakers for its upcoming Research and Innovation conference taking place at the University of Manchester from 20–21 March. Steve Bates OBE FMedSci, CEO, BioIndustry Association (BIA) and Dr Anderson Ryan, Co-founder and Head of R&D and Drug Development, FasT BioPharma will lead this year’s event which will focus on accelerating drug discovery.

8 February 2024Press Releases
Closed Loop Medicine demonstrates application of novel drug plus software product for personalized
Closed Loop Medicine demonstrates application of novel drug plus software product for personalized

Closed Loop Medicine Ltd., a leading TechBio company developing combination prescription drug plus software therapy products that deliver personalized dose optimization, today announced the publication of a peer-reviewed study in the Journal of the American Heart Association (JAHA) (1).

8 February 2024Press Releases
 LogiPharma Unveils Dedicated Conference Tracks for 2024
LogiPharma Unveils Dedicated Conference Tracks for 2024

Ahead of its highly anticipated 2024 edition, LogiPharma, the world’s largest life sciences supply chain event, has revealed more details about how guests can tailor their experience across a variety of important industry topics. Due to take place in Lyon, France this 16-18th April, the three-day conference will feature six distinct tracks each occupying a dedicated room.

8 February 2024Press Releases
PacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications
PacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications

., Feb. 5, 2024 /PRNewswire/ — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced two new high throughput library preparation kits and workflows optimized for its Revio sequencing system. With these kits, PacBio takes another leap forward in the long-read market by offering customers automated, scalable, and high-performance library preparation solutions with a 40 percent reduction in costs and a

7 February 2024Press Releases
Game-Changing ‘Audit Trail Review’ Application Secures ACDM 2024 Awards Nomination for CluePoints
Game-Changing ‘Audit Trail Review’ Application Secures ACDM 2024 Awards Nomination for CluePoints

CluePoints, providers of best-in-class statistical and AI-driven software solutions, has been shortlisted for the 2024 Annual Association of Clinical Data Management (ACDM24) Awards, in the category of Innovation in the Management of Clinical Data. The 2024 Winners will be announced at ACDM24 on March 4th in Copenhagen, Denmark.

7 February 2024Press Releases
Data on over 2,300 Lung Cancer Biomarkers Mapped in New Global Database
Data on over 2,300 Lung Cancer Biomarkers Mapped in New Global Database

A new database has been created to support pharmaceutical and biotech companies in the creation of new drugs to treat lung cancer, bringing the creation of personalised treatment for people fighting the disease one step closer.

1 February 2024Press Releases
Enhanc3D Genomics appoints Dr Daniel Turner as Chief Scientific Officer
Enhanc3D Genomics appoints Dr Daniel Turner as Chief Scientific Officer

Enhanc3D Genomics, a company developing disruptive technologies to unlock the 3D spatial genome for target and biomarker discovery, today announced the appointment of Dr Daniel Turner as Chief Scientific Officer (CSO). Dan’s deep expertise in genomics technology development and commercialisation will be key to achieving the next phase of Enhanc3D Genomics’ growth.

31 January 2024Press Releases
Yokogawa introduces CellVoyager High-Content Analysis System CQ3000
Yokogawa introduces CellVoyager High-Content Analysis System CQ3000

Yokogawa Electric Corporation (TOKYO: 6841) today announced the introduction of the CQ3000, a high-content analysis system for capturing high-definition 3D microscopic images of live cell cultures. Expanding the company’s CellVoyager™ family of products, the CQ3000 will be launched commercially later in 2024.

31 January 2024Press Releases
 CN Bio appoints Joseph Parisi as US Director of Sales to support accelerated growth in key OOC mark
CN Bio appoints Joseph Parisi as US Director of Sales to support accelerated growth in key OOC mark

: CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single- and multi-organ microphysiological systems (MPS), today announced the appointment of Joseph Parisi as US Director of Sales. In his new role, Joe will lead the expansion of the Company’s sales and support activities for the US market to address the growing demand for new alternative methodologies (NAMs) in preclinical drug discovery.

30 January 2024Press Releases
New genetic test to speed up and streamline diagnosis of inherited cancers
New genetic test to speed up and streamline diagnosis of inherited cancers

Genetic testing company, Nonacus, has launched its latest next generation sequencing (NGS) test in the GALEAS product range – the GALEAS Hereditary Plus panel – which provides laboratories and clinicians with a comprehensive and streamlined way to diagnose patients with cancer that is caused by inherited genetic mutations.

29 January 2024Press Releases
 Pistoia Alliance launches freely available IDMP Ontology 1.0, covering all five standards set by
Pistoia Alliance launches freely available IDMP Ontology 1.0, covering all five standards set by

. The Pistoia Alliance, a global not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has published its Identification of Medicinal Products (IDMP) Ontology 1.0 under an open-source license.

29 January 2024Press Releases